Evolus, Inc.
Evolus develops aesthetic injectable products including Jeuveau (prabotulinumtoxinA-xvfs), a neurotoxin; Evolysse, hyaluronic acid gels; and Profhilo, an injectable for skin quality.
8-KSep 30Latest SEC filing
Aug 31Latest story
Sign inSign inEvolus develops aesthetic injectable products including Jeuveau (prabotulinumtoxinA-xvfs), a neurotoxin; Evolysse, hyaluronic acid gels; and Profhilo, an injectable for skin quality.